Cargando…

Sex hormones and oesophageal adenocarcinoma: influence of childbearing?

The male predominance of oesophageal adenocarcinoma might be explained by oestrogen protection in women. If true, female patients might have sex hormonal disturbances rendering impaired fertility. The influence of childbearing on the risk of oesophageal adenocarcinoma was investigated in a Swedish p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lagergren, J, Jansson, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361653/ https://www.ncbi.nlm.nih.gov/pubmed/16189516 http://dx.doi.org/10.1038/sj.bjc.6602810

Ejemplares similares

Sex-specific risk factor profile in oesophageal adenocarcinoma
por: Löfdahl, H E, et al.
Publicado: (2008)

Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
por: Lindblad, M, et al.
Publicado: (2006)

Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma
por: Rutegård, M, et al.
Publicado: (2010)

A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers
por: Wu, C, et al.
Publicado: (2015)

Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety
por: Villanueva, Luis, et al.
Publicado: (2021)

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
por: Wainberg, Z A, et al.
Publicado: (2011)

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
por: Starling, N, et al.
Publicado: (2009)

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
por: Feilchenfeldt, J, et al.
Publicado: (2015)

A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma
por: Mirza, A., et al.
Publicado: (2013)

Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
por: Donlon, Noel E, et al.
Publicado: (2022)

The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer
por: Deans, D A C, et al.
Publicado: (2009)

Value of histomorphometric tumour thickness and smoothelin for conventional m-classification in early oesophageal adenocarcinoma
por: Endhardt, Katharina, et al.
Publicado: (2017)

Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
por: Pinto, C, et al.
Publicado: (2009)

Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
por: Xie, Shao‐Hua, et al.
Publicado: (2020)

Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data
por: Janowitz, Tobias, et al.
Publicado: (2016)

Hiatus Hernia Repair with Bilateral Oesophageal Fixation
por: Mendis, Rajith, et al.
Publicado: (2015)

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
por: Shimodaira, Yusuke, et al.
Publicado: (2018)

Staging investigations for oesophageal cancer: a meta-analysis
por: van Vliet, E P M, et al.
Publicado: (2008)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

Small cell oesophageal carcinoma: an institutional experience and review of the literature
por: Hudson, E, et al.
Publicado: (2007)

Combined modality chemoradiation in elderly oesophageal cancer patients
por: Anderson, S E, et al.
Publicado: (2007)

Functional Magnetic Resonance in the Evaluation of Oesophageal Motility Disorders
por: Covotta, Francesco, et al.
Publicado: (2011)

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
por: Blazeby, J M, et al.
Publicado: (2014)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
por: Tougeron, D, et al.
Publicado: (2008)

Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study
por: Holmberg, Dag, et al.
Publicado: (2023)

The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands
por: van Vliet, E P M, et al.
Publicado: (2006)

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma
por: Kurashige, J, et al.
Publicado: (2012)

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
por: Millar, J, et al.
Publicado: (2005)

Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis
por: van Vliet, E P M, et al.
Publicado: (2007)

Influence of Running and Walking on Hormonal Regulators of Appetite in Women
por: Larson-Meyer, D. Enette, et al.
Publicado: (2012)

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
por: Neale, R E, et al.
Publicado: (2009)

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
por: Neale, R E, et al.
Publicado: (2009)

The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer
por: McKernan, M, et al.
Publicado: (2008)

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response
por: Gillham, C M, et al.
Publicado: (2006)

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
por: Conroy, T, et al.
Publicado: (2008)

Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?
por: Park, Jin-Soo, et al.
Publicado: (2021)

Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction
por: Li, Minmin, et al.
Publicado: (2014)

Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study
por: Kauppila, Joonas H, et al.
Publicado: (2018)

Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden
por: Chandanos, E, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dpoho4lbv2413ub4k31scru3q3